Prospeo
Hero Section BackgroundHero Section Background
InGel Therapeutics

InGel Therapeutics Email Formats

Biotechnology ResearchFlag of USBoston, Massachusetts, United States1-10 Employees

Key Contacts at InGel Therapeutics

Flag of US

Patrick Jiang

Co-Founder And Ceo

Flag of US

Pierre Colombe Dromel

Cto And Co-Founder

Flag of US

Deepti Singh

Founder And Chief Scientific Officer

Company overview

HeadquartersBoston, Massachusetts, United States
Phone number+16179490833
Website
NAICS541714
Founded2022
Employees1-10
Socials

About InGel Therapeutics

InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite
Founder/Owner

Employees by Department

InGel Therapeutics has 3 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore InGel Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2022-12-212N/A
2024-08-163N/A

Funding Insights

2

Number of funding rounds

Frequently asked questions

InGel Therapeutics is located in Boston, Massachusetts, US.
You can reach InGel Therapeutics at +16179490833.
InGel Therapeutics was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.
InGel Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles